David Mathai, MD

I am a board-certified psychiatrist with advanced training as a behavioral pharmacologist and postdoctoral fellow with the Johns Hopkins Center for Psychedelics and Consciousness Research. I completed medical school and residency training with Baylor College of Medicine and the Menninger Department of Psychiatry and Behavioral Sciences, receiving awards for excellence in psychotherapy and research. I am also a graduate of Texas A&M University, where I studied Biochemistry, Genetics, and English, and graduated with University Honors and Honors Fellows Distinctions. As a physician-scientist, I have investigated and produced numerous scientific publications on topics such as behavioral models of addiction and cognitive impairment, the neuropsychiatric effects of cannabis, and the complex properties of psychedelic-type therapies like ketamine, MDMA, and psilocybin. I have worked as a scientific collaborator, study physician, and session therapist for multiple clinical trials of psilocybin-assisted interventions. These opportunities have for me highlighted the unique potential for psychedelics to facilitate healing and enhance wellbeing when used under appropriate conditions. I am committed to the eventual development of these tools within healthcare infrastructures that are safe, sustainable, and put people first.